
Agilent Technologies Inc
A · Healthcare · Life Sciences Tools & Services
Updated 25 min ago · data delayed ≥15 min
IconicScore
ProprietaryRanked #229 of 500 by Iconic Score · #31 of 59in its sector. IconicAlpha’s proprietary brand-intelligence metric — a multi-model blend of scale, market attention, category leadership, and AI-analyzed brand visibility.
Get the free morning email
The biggest IconicScore™ gainer and loser, plus the strongest and weakest sectors, in your inbox before the open. See a sample →
Price performance
Export history · AnalystThis insight is part of the Analyst tier — unlock the IconicScore vs. price overlay, side-by-side comparison, and CSV export.
Upgrade to AnalystThis is part of the Enterprise tier — benchmark your IconicScore against sector peers, claim your profile, and manage how your brand appears on the wall.
Upgrade to EnterpriseIconic Profile
Agilent Technologies Inc. is a leading player in the Healthcare sector, specifically within Life Sciences Tools & Services, with a market capitalization of $37.4 billion. The company specializes in providing analytical instruments, software, and services that support laboratories in various fields, including pharmaceuticals, biotechnology, environmental testing, and food safety. Agilent's innovative solutions enable researchers and scientists to enhance their productivity and improve the accuracy of their results. With a strong focus on quality and customer satisfaction, Agilent holds a significant market position, benefiting from the growing demand for advanced analytical technologies and the increasing emphasis on precision medicine. Its commitment to innovation and sustainability further solidifies its relevance in the evolving healthcare landscape, making it a crucial player in driving advancements in scientific research and diagnostics.
IconicOracleAI™ Brief
Agilent Technologies Inc currently holds an Iconic Score of 51, reflecting moderate brand recognition and market presence. The company benefits from strong visibility, evidenced by an 85/100 brand-visibility signal from logo analysis, and is recognized for its solid returns and cash flow. Recent market discussions highlight Agilent's leadership in the bioconjugation sector alongside competitors, contributing to its perceived quality in the industry.
AI-generated explanation of current score drivers. Not investment advice.
Enterprise tier: claim your logo to manage how your brand is represented.